Showing results (41-50 of 83) with videos related to

Sort By:
Pageof 9
Transplantation and Cellular Therapy|September 6, 2023
Outcomes of Autologous Stem Cell Transplantation in Patients with Ultra-High-Risk Multiple MyelomaOren Pasvolsky, Sassine Ghanem, Denái R Milton, et al.
Cancer|December 21, 2023
Impact of pretransplant minimal residual disease in patients with multiple myeloma and a very good partial response or better receiving autologous hematopoietic stem cell transplantationOren Pasvolsky, Sarah Pasyar, Roland L Bassett, et al.
British Journal of Haematology|March 6, 2024
Impact of revised International Staging System 2 risk stratification on outcomes of patients with multiple myeloma receiving autologous haematopoietic stem cell transplantationKamal Alzahrani, Oren Pasvolsky, Zhongya Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 12, 2021
Nine-Year Follow-up of Patients with Relapsed Follicular Lymphoma after Nonmyeloablative Allogeneic Stem Cell Transplant and Autologous TransplantIssa F Khouri, Denái R Milton, Alison M Gulbis, et al.
American Journal of Hematology|July 18, 2023
Single-agent lenalidomide maintenance after upfront autologous stem cell transplant for newly diagnosed multiple myeloma: The MD Anderson experienceOren Pasvolsky, Denái R Milton, Adeel Masood, et al.
British Journal of Haematology|June 28, 2023
Outcomes of young adults (aged ≤ 40 years) with newly diagnosed multiple myeloma after up-front autologous stem cell transplantOren Pasvolsky, Curtis Marcoux, Denái R Milton, et al.
Blood Cancer Journal|May 17, 2024
Multiple myeloma patients with a long remission after autologous hematopoietic stem cell transplantationOren Pasvolsky, Zhongya Wang, Denái R Milton, et al.
Transplantation and Cellular Therapy|January 16, 2023
Autologous Stem Cell Transplantation for Patients with Multiple Myeloma with Translocation (4;14): The MD Anderson Cancer Center ExperienceOren Pasvolsky, Mahmoud R Gaballa, Denái R Milton, et al.
British Journal of Haematology|July 6, 2026
Carfilzomib, lenalidomide, and dexamethasone (KRd) versus bortezomib, lenalidomide, and dexamethasone (VRd) induction prior to autologous haematopoietic stem cell transplant/transplantation in newly diagnosed multiple myelomaCurtis Marcoux, Denái R Milton, Mark R Tanner, et al.
Clinical Lymphoma, Myeloma & Leukemia|December 21, 2024
Outcome of Patients With Central Nervous System Multiple Myeloma (CNS-MM) Treated With CNS-Directed Radiation TherapyGohar S Manzar, Stephanie O Dudzinski, Alison K Yoder, et al.
Pageof 9